- Home
- TNGX vs SBET Comparison
TNGX vs SBET Comparison
Compare TNGX & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SBET
- Stock Information
- Founded
- TNGX 2014
- SBET 1995
- Country
- TNGX United States
- SBET United States
- Employees
- TNGX N/A
- SBET N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- SBET Technology
- Exchange
- TNGX Nasdaq
- SBET Nasdaq
- Market Cap
- TNGX 723.0M
- SBET 618.0M
- IPO Year
- TNGX N/A
- SBET 1997
- Fundamental
- Price
- TNGX $6.53
- SBET $17.14
- Analyst Decision
- TNGX Strong Buy
- SBET
- Analyst Count
- TNGX 5
- SBET 0
- Target Price
- TNGX $10.50
- SBET N/A
- AVG Volume (30 Days)
- TNGX 1.9M
- SBET 55.8M
- Earning Date
- TNGX 08-05-2025
- SBET 08-14-2025
- Dividend Yield
- TNGX N/A
- SBET N/A
- EPS Growth
- TNGX N/A
- SBET N/A
- EPS
- TNGX N/A
- SBET N/A
- Revenue
- TNGX $40,990,000.00
- SBET $3,428,134.00
- Revenue This Year
- TNGX N/A
- SBET N/A
- Revenue Next Year
- TNGX N/A
- SBET N/A
- P/E Ratio
- TNGX N/A
- SBET N/A
- Revenue Growth
- TNGX 10.09
- SBET N/A
- 52 Week Low
- TNGX $1.03
- SBET $2.26
- 52 Week High
- TNGX $12.02
- SBET $124.12
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- SBET 43.68
- Support Level
- TNGX $6.36
- SBET $18.37
- Resistance Level
- TNGX $7.11
- SBET $28.50
- Average True Range (ATR)
- TNGX 0.52
- SBET 4.91
- MACD
- TNGX -0.13
- SBET -1.06
- Stochastic Oscillator
- TNGX 53.15
- SBET 0.21
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.